Company Search:
Advanced Search
Sponsored Links
Tella Incorporation Company Snapshot
Tella Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other companies in this sector in Japan: Trans Genic Inc (2016 sales of 2.29 billion Japanese Yen [US$20.59 million] of which 48% was CRO Business), Japan Tissue Engineering Company Limited (1.43 billion Japanese Yen [US$12.86 million] of which 93% was Regenerative Medicine Products Business), and Medinet Co., Ltd. (1.91 billion Japanese Yen [US$17.16 million] of which 98% was cell processing).

Sales Analysis. Tella Incorporation reported sales of ¥1.80 billion (US$16.20 million) for the year ending December of 2016. This represents a decrease of 5.6% versus 2015, when the company's sales were ¥1.91 billion. Contributing to the drop in overall sales was the 21.9% decline in Cell Therapy Technology Development Busi, from ¥1.03 billion to ¥807.08 million. . However, these declines were partially offset by the increase in sales of Cell Therapy Support Business (up 19.2% to ¥994.76 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tella Incorporation
  Stock Performance Chart for Tella Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 527.00
(Figures in Japanese Yen)
1 Week -6.9%   13 Weeks 4.8%  
4 Weeks 11.9%   52 Weeks 1.5%  
Tella Incorporation Key Data:
  Ticker: 2191 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,801,837,000
(Year Ending Jan 2017).
Employees: 71
  Currency: Japanese Yen Market Cap: 8,958,421,881
  Fiscal Yr Ends: December Shares Outstanding: 16,998,903
  Share Type: Common Closely Held Shares: 3,878,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.